Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases

DSpace Repository

Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases

Author: Heidecker, Bettina; Dagan, Noa; Balicer, Ran; Eriksson, Urs; Rosano, Giuseppe; Coats, Andrew; Tschoepe, Carsten; Kelle, Sebastian; Poland, Gregory A.; Frustaci, Andrea; Klingel, Karin; Martin, Pilar; Hare, Joshua M.; Cooper, Leslie T.; Pantazis, Antonis; Imazio, Massimo; Prasad, Sanjay; Luscher, Thomas F.
Tübinger Autor(en):
Klingel, Karin
Published in: European Journal of Heart Failure (2022), Bd. 24, H. 11, S. 2000-2018
Verlagsangabe: Wiley
Language: English
Full text: http://dx.doi.org/10.1002/ejhf.2669
ISSN: 1388-9842
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)